Send to

Choose Destination
Elife. 2015 Aug 24;4. doi: 10.7554/eLife.08088.

Small molecule inhibition of Csk alters affinity recognition by T cells.

Author information

Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center, Division of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, United States.
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.
Departments of Biomedicine and Nephrology, University Hospital Basel, University of basel, Basel, Switzerland.


The C-terminal Src kinase (Csk), the primary negative regulator of Src-family kinases (SFK), plays a crucial role in controlling basal and inducible receptor signaling. To investigate how Csk activity regulates T cell antigen receptor (TCR) signaling, we utilized a mouse expressing mutated Csk (Csk(AS)) whose catalytic activity is specifically and rapidly inhibited by a small molecule. Inhibition of Csk(AS) during TCR stimulation led to stronger and more prolonged TCR signaling and to increased proliferation. Inhibition of Csk(AS) enhanced activation by weak but strictly cognate agonists. Titration of Csk inhibition revealed that a very small increase in SFK activity was sufficient to potentiate T cell responses to weak agonists. Csk plays an important role, not only in basal signaling, but also in setting the TCR signaling threshold and affinity recognition.


Src kinases; cell biology; immunology; lymphocyte; mouse; receptors; signal transduction; tyrosine phosphorylation

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for eLife Sciences Publications, Ltd Icon for PubMed Central
Loading ...
Support Center